Status: current, Defined. Date: 30-Jun 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3351191000168110 | Asasantin SR (aspirin 25 mg + dipyridamole 200 mg) modified release capsule, 30 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3351201000168113 | Asasantin SR modified release capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Asasantin SR modified release capsule, 30 | Is a | dipyridamole 200 mg + aspirin 25 mg modified release capsule, 30 | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Asasantin SR modified release capsule, 30 | has TPUU | Asasantin SR modified release capsule | true | Inferred relationship | Some | 1 | |
| Asasantin SR modified release capsule, 30 | has TP | Asasantin SR | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Asasantin SR modified release capsule, 30, bottle | Is a | True | Asasantin SR modified release capsule, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR